Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
Arix collaborates with exceptional entrepreneurs and provides the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. As a listed company, Arix is able to bring this exciting growth phase of their industry to a broader range of investors.
Lead analyst: Dr Martin Hall
If you'd like to be introduced to the team at Arix Bioscience, get in touch.Request a meeting